Sneha Vivekanandhan

Sneha Vivekanandhan is a Scientist at Champions Oncology, Inc. since July 2022, previously serving as a Senior Research Fellow at Mayo Clinic School of Medicine from January 2019 to July 2022, where Sneha led projects focused on immune responses and cancer therapy. Prior experience includes serving as a Graduate Student at Mayo Clinic from July 2012 to May 2018, investigating the influence of KRAS genetic status on TGF-β signaling in tumorigenesis. Sneha's earlier roles include Research Technician positions at The Johns Hopkins University School of Medicine, studying protein expression in cancers and the effects of fluconazole on apoptosis. Sneha holds a PhD in Biochemistry and Molecular Biology from Mayo Clinic Graduate School of Biomedical Sciences, a Master's in Biotechnology from The Johns Hopkins University, and Bachelor's degrees in Biotechnology from Ansal University Gurgaon and North Dakota State University.